In cancer, K63-linked ubiquitination has been observed to promote activation of oncogenic kinases including Akt and TAK1 (177) and various DNA damage response factors including CLASPIN (178), both leading to enhanced tumorigenesis. This evidence concerns the gene CLSPN and cancer.